Lipoprotein storage disorders manifest as a heterogeneous group of genetic metabolic diseases. These conditions are characterized lipozem by the build-up of abnormal lipoproteins, primarily within the cells, leading to a spectrum of clinical manifestations. The underlying mechanisms involve defects in the synthesis of apolipoproteins or enzymes inv